Erratum to: HDAC2 phosphorylation-dependent Klf5 deacetylation and RARα acetylation induced by RAR agonist switch the transcription regulatory programs of p21 in VSMCs (Cell Research, (2011), 21, 10, (1487-1508), 10.1038/cr.2011.34);HDAC2 phosphorylation-dependent Klf5 deacetylation and RARα acetylation induced by RAR agonist switch the transcription regulatory programs of p21 in VSMCs

Cell Research

Volumn 21, Issue 10, 2011, Pages 1487-1508

  Zheng, Bin ^a   Han, Mei ^a   Shu, Ya Nan ^a   Li, Ying Jie ^a   Miao, Sui Bing ^a   Zhang, Xin Hua ^a   Shi, Hui Jing ^a   Zhang, Tian ^a   Wen, Jin Kun ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

gene expression; Kr ppel like factor 5; p21; retinoic acid receptor ; signal transduction; vascular smooth muscle cells

Indexed keywords

EID: 80053642561     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/s41422-024-00947-y     Document Type: Erratum

References (67)

1. Francis DJ, Parish CR, McGarry M, et al. Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation. Circ Res 2003;92:e70-77.
2. Dzau VJ, Braun-Dullaeus RC, Sedding DG. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med 2002;8:1249-1256. (Pubitemid 35373556)
3. Suzuki T, Sawaki D, Aizawa K, et al. Kruppel-like factor 5 shows proliferation-specific roles in vascular remodeling, direct stimulation of cell growth, and inhibition of apoptosis. J Biol Chem 2009;284:9549-9557.
4. Kunieda T, Minamino T, Nishi J, et al. Angiotensin II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway. Circulation 2006;114:953-960. (Pubitemid 44337139)
5. Weinberg WC, Denning MF. P21Waf1 control of epithelial cell cycle and cell fate. Crit Rev Oral Biol Med 2002;13:453-464. (Pubitemid 36570019)
6. Avkin S, Sevilya Z, Toube L, et al. p53 and p21 regulate error-prone DNA repair to yield a lower mutation load. Mol Cell 2006;22:407-413.
7. Mattiussi S, Turrini P, Testolin L, et al. p21 (Waf1/Cip1/Sdi1) mediates shear stress-dependent antiapoptotic function. Cardiovasc Res 2004;61:693-704. (Pubitemid 38249468)
8. Condorelli G, Aycock, JK, Frati G, Napoli C. Mutated p21/WAF/CIP transgene overexpression reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice. FASEB J 2001;15:2162-2170. (Pubitemid 32927933)
9. Olive M, Mellad JA, Beltran LE, et al. p21Cip1 modulates arterial wound repair through the stromal cell-derived factor-1/CXCR4 axis in mice. J Clin Invest 2008;118:2050-2061. (Pubitemid 351872325)
10. Otterbein LE, Zuckerbraun BS, Haga M, et al. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 2003;9:183-190. (Pubitemid 36227720)
11. Adimoolam S, Lin CX, Ford JM. The p53-regulated cyclindependent kinase inhibitor, p21 (cip1, waf1, sdi1), is not required for global genomic and transcription-coupled nucleotide excision repair of UV-induced DNA photoproducts. J Biol Chem 2001;276:25813-25822.
12. Agrawal S, Agarwal ML, Chatterjee-Kishore M, Stark GR, Chisolm GM. Stat1-dependent, p53-independent expression of p21 (waf1) modulates oxysterol-induced apoptosis. Mol Cell Biol 2002;22:1981-1992. (Pubitemid 34224607)
13. Luo P, Lin M, Lin M, et al. Function of retinoid acid receptor alpha and p21 in all-trans-retinoic acid-induced acute T-lymphoblastic leukemia apoptosis. Leuk Lymphoma 2009;50:1183-1189.
14. Tanaka T, Suh KS, Lo AM, De Luca LM. p21WAF1/CIP1 is a common transcriptional target of retinoid receptors: pleiotropic regulatory mechanism through retinoic acid receptor (RAR)/retinoid X receptor (RXR) heterodimer and RXR/RXR homodimer. J Biol Chem 2007;282:29987-29997. (Pubitemid 350035294)
15. Narla G, Kremer-Tal S, Matsumoto N, et al. In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma. Oncogene 2007;26:4428-4434. (Pubitemid 47014461)
16. Yoshida T, Kaestner KH, Owens GK. Conditional deletion of Kruppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury. Circ Res 2008;102:1548-1557.
17. Ghaleb AM, Nandan MO, Chanchevalap S, et al. Kruppellike factors 4 and 5: the yin and yang regulators of cellular proliferation. Cell Res 2005;15:92-96. (Pubitemid 41653948)
18. Sue YM, Chung CP, Lin H, et al. PPARdelta-mediated p21/p27 induction via increased CREB-binding protein nuclear translocation in beraprost-induced antiproliferation of murine aortic smooth muscle cells. Am J Physiol Cell Physiol 2009;297:C321-C329.
19. Mottet D, Pirotte S, Lamour V, et al. HDAC4 represses p21 (WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism. Oncogene 2009;28:243-256.
20. Kim JK, Esteve PO, Jacobsen SE, Pradhan S. UHRF1 binds G9a and participates in p21 transcriptional regulation in mammalian cells. Nucleic Acids Res 2009;37:493-505.
21. Bond M, Sala-Newby GB, Wu YJ, Newby AC. Biphasic effect of p21Cip1 on smooth muscle cell proliferation: role of PI 3-kinase and Skp2-mediated degradation. Cardiovasc Res 2006;69:198-206. (Pubitemid 41818971)
22. Zhang WQ, Geiman DE, Shields JM, et al. The Gut-enriched krüppel-like factor (krüppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter. J Biol Chem 2000;275:18391-18398. (Pubitemid 30414796)
23. He M, Han M, Zheng B, Shu YN, Wen JK. Angiotensin II stimulates KLF5 phosphorylation and its interaction with c-Jun. leading to suppression of p21 expression in vascular smooth muscle cells. J Biochem 2009;146:683-691.
24. Wassmann S, Wassmann K, Jung A, et al. Induction of p53 by GKLF is essential for inhibition of proliferation of vascular smooth muscle cells. J Mol Cell Cardiol 2007;43:301-307. (Pubitemid 47301935)
25. Zhang XH, Zheng B, Han M, Miao SB, Wen JK. Synthetic retinoid Am80 inhibits interaction of KLF5 with RAR alpha through inducing KLF5 dephosphorylation mediated by the PI3K/Akt signaling in vascular smooth muscle cells. FEBS Lett 2009;583:1231-1236.
26. Liu R, Zheng HQ, Zhou Z, Dong JT, Chen C. KLF5 promotes breast cell survival partially through fibroblast growth factorbinding protein 1-pERK-mediated dual specificity MKP-1 protein phosphorylation and stabilization. J Biol Chem 2009;284:16791-16798.
27. Miano JM, Topouzis S, Majesky MW, Olson EN. Retinoid receptor expression and all-trans retinoic acid-mediated growth inhibition in vascular smooth muscle cells. Circulation 1996;93:1886-1895.
28. Miano JM, Kelly LA, Artacho CA, et al. all-Trans-retinoic acid reduces neointimal formation and promotes favorable geometric remodeling of the rat carotid artery after balloon withdrawal injury. Circulation 1998;98:1219-1227. (Pubitemid 28436173)
29. Axel DI, Frigge A, Dittmann J, et al. All-trans retinoic acid regulates proliferation, migration, differentiation, and extracellular matrix turnover of human arterial smooth muscle cells. Cardiovas Res 2001;49:851-862. (Pubitemid 32178389)
30. Wiegman PJ, Barry WL, McPherson JA, et al. All-transretinoic acid limits restenosis after balloon angioplasty in the focally atherosclerotic rabbit: a favorable effect on vessel remodeling. Arterioscler Thromb Vasc Biol 2000;20:89-95. (Pubitemid 30048350)
31. Herdeg C, Oberhoff M, Baumbach A, et al. Effects of local all-trans-retinoic acid delivery on experimental atherosclerosis in the rabbit carotid artery. Cardiovasc Res 2003;57:544-553. (Pubitemid 36144231)
32. Germain P, Iyer J, Zechel C, Gronemeyer H. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Nature 2002;415:187-192. (Pubitemid 34059522)
33. Charoensit P, Kawakami S, Higuchi Y, Yamashita F, Hashida M. Enhanced growth inhibition of metastatic lung tumors by intravenous injection of ATRA-cationic liposome/IL-12 pDNA complexes in mice. Cancer Gene Ther 2010;17:512-522.
34. Fujiu K, Manabe I, Ishihara A, et al. Synthetic retinoid Am80 suppresses smooth muscle phenotypic modulation and instent neointima formation by inhibiting KLF5. Circ Res 2005;97:1132-1141.
35. Adenuga D, Rahman I. Protein kinase CK2-mediated phosphorylation of HDAC2 regulates co-repressor formation, deacetylase activity and acetylation of HDAC2 by cigarette smoke and aldehydes. Arch Biochem Biophys 2010;498:62-73.
36. Tsai SC, Seto E. Regulation of histone deacetylase 2 by protein kinase CK2. J Biol Chem 2002;277:31826-31833. (Pubitemid 34968989)
37. Miyamoto S, Suzuki T, Muto S, et al. Positive and negative regulation of the cardiovascular transcription factor KLF5 by p300 and the oncogenic regulator SET through interaction and acetylation on the DNA-binding domain. Mol Cell Biol 2003;23:8528-8541. (Pubitemid 37433360)
38. Guo P, Zhao KW, Dong XY, Sun X, Dong JT. Acetylation of KLF5 alters the assembly of p15 transcription factors in transforming growth factor-beta-mediated induction in epithelial cells. J Biol Chem 2009;284:18184-18193.
39. Eberharter A, Becker PB. Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics. EMBO Rep 2002;3:224-229. (Pubitemid 34269514)
40. Marks PA, Richon VM, Miller T, et al. Histone deacetylase inhibitors. Adv Cancer Res 2004;91:137-168. (Pubitemid 39140958)
41. Zimmermann S, Kiefer F, Prudenziati M, et al. Reduced body size and decreased intestinal tumor rates in HDAC2-mutant mice. Cancer Res 2007;67:9047-9054. (Pubitemid 47535889)
42. Rössig L, Urbich C, Brühl T, et al. Histone deacetylase activity is essential for the expression of HoxA9 and for endothelial commitment of progenitor cells. J Exp Med 2005;201:1825-1835. (Pubitemid 41002901)
43. Peinado H, Ballestar E, Esteller M, et al. Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol Cell Biol 2004;24:306-319. (Pubitemid 38010056)
44. Li J, Wang J, Wang J, et al. Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J 2000;19:4342-4350. (Pubitemid 30623745)
45. Meng F, Han M, Zheng B, et al. All-trans retinoic acid increases KLF4 acetylation by inducing HDAC2 phosphorylation and its dissociation from KLF4 in vascular smooth muscle cells. Biochem Biophys Res Commun 2009;387:13-18.
46. Yoshida T, Gan Q, Owens GK. Krüppel-like factor 4, Elk-1, and histone deacetylases cooperatively suppress smooth muscle cell differentiation markers in response to oxidized phospholipids. Am J Physiol Cell Physiol 2008;295:C1175-C1182. (Pubitemid 352790337)
47. van Wely KH, Molijn AC, Buijs A, et al. The MN1 oncoprotein synergizes with coactivators RAC3 and p300 in RAR-RXR-mediated transcription. Oncogene 2003;22:699-709. (Pubitemid 36269283)
48. Lin YC, Lin JH, Chou CW, et al. Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2. Cancer Res 2008;68:2375-2383.
49. Delarue FL, Adnane J, Joshi B, et al. Farnesyltransferase and geranylgeranyltransferase I inhibitors upregulate RhoB expression by HDAC1 dissociation, HAT association and histone acetylation of the RhoB promoter. Oncogene 2007;26:633-640. (Pubitemid 46204243)
50. Ryu H, Lee J, Olofsson BA, et al. Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway. Proc Natl Acad Sci USA 2003;100:4281-4286. (Pubitemid 36418194)
51. Zheng B, Han M, Bernier M, et al. Kruppel-like factor 4 inhibits proliferation by platelet-derived growth factor receptor beta-mediated, not by retinoic acid receptor alpha-mediated, phosphatidylinositol 3-kinase and ERK signaling in vascular smooth muscle cells. J Biol Chem 2009;284:22773-22785.
52. Chen LF, Williams SA, Mu Y, et al. NF-kappaB RelA phosphorylation regulates RelA acetylation. Mol Cell Biol 2005;25:7966-7975. (Pubitemid 41262991)
53. Elmazar MM, Nau H. Potentiation of the teratogenic effects induced by coadministration of retinoic acid or phytanic acid/phytol with synthetic retinoid receptor ligands. Arch Toxicol 2004;78:660-668. (Pubitemid 40064326)
54. Dong LH, Wen JK, Liu G, et al. Blockade of the Ras-extracellular signal-regulated kinase 1/2 pathway is involved in smooth muscle 22 alpha-mediated suppression of vascular smooth muscle cell proliferation and neointima hyperplasia. Arterioscler Thromb Vasc Biol 2010;30:683-691.
55. Nofsinger RR, Li P, Hong SH, et al. SMRT repression of nuclear receptors controls the adipogenic set point and metabolic homeostasis. Proc Natl Acad Sci USA 2008;105:20021-20026.
56. Chanchevalap S, Nandan MO, McConnell BB, et al. Kruppellike factor 5 is an important mediator for lipopolysaccharideinduced proinflammatory response in intestinal epithelial cells. Nucleic Acids Res 2006;34:1216-1223.
57. Choi YB, Ko JK, Shin J. The transcriptional corepressor, PELP1, recruits HDAC2 and masks histones using two separate domains. J Biol Chem 2004;279:50930-50941. (Pubitemid 40017832)
58. Flinterman MB, Mymryk JS, Klanrit P, et al. p400 function is required for the adenovirus E1A-mediated suppression of EGFR and tumour cell killing. Oncogene 2007;26:6863-6874. (Pubitemid 47609077)
59. Macleod KF, Sherry N, Hannon G, et al. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 1995;9:935-944.
60. Zheng B, Han M, Wen JK, Zhang R. Human heart LIM protein activates atrial-natriuretic-factor gene expression by interacting with the cardiac-restricted transcription factor Nkx2.5. Biochem J 2008;409:683-690. (Pubitemid 351214194)
61. Li HX, Han M, Bernier M, et al. Kruppel-like factor 4 promotes differentiation by transforming growth factor-beta receptor-mediated Smad and p38 MAPK signaling in vascular smooth muscle cells. J Biol Chem 2010;285:17846-17856.
62. Han M, Wen JK, Zheng B, Cheng Y, Zhang C. Serum deprivation results in redifferentiation of human umbilical vascular smooth muscle cells. Am J Physiol Cell Physiol 2006;291:C50-C58.
63. Zheng B, Wen JK, Han M. hhLIM is a novel F-actin binding protein involved in actin cytoskeleton remodeling. FEBS J 2008;275:1568-1578. (Pubitemid 351388802)
64. Han M, Li AY, Meng F, et al. Synergistic co-operation of signal transducer and activator of transcription 5B with activator protein 1 in angiotensin II-induced angiotensinogen gene activation in vascular smooth muscle cells. FEBS J 2009;276:1720-1728.
65. Liu B, Han M, Wen JK. Acetylbritannilactone inhibits neointimal hyperplasia after balloon injury of rat artery by suppressing nuclear factor-{kappa}B activation. J Pharmacol Exp Ther 2008;324:292-298. (Pubitemid 350294152)
66. Sun SG, Zheng B, Han M, et al. miR-146a and Krüppellike factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation. EMBO Rep 2011;12:56-62.
67. Wu L, Li X, Li Y, et al. Proliferative inhibition of danxiongfang and its active ingredients on rat vascular smooth muscle cell and protective effect on the VSMC damage induced by hydrogen peroxide. J Ethnopharmacol 2009;126:197-206.